biotechnology

When we look at the challenges affecting our world today, many come to mind - energy demand, food security and climate change, just to name a few.

Biotechnology provides tools to meet all of these challenges. The sustainable farming practices afforded to today’s modern farmers allow us to produce more food, fuel and fiber on less land with less environmental impact.

These technologies – and the policies and infrastructures needed to realize their benefit – will be the focus of a very important panel discussion taking place here in Washington on February 12th.

When we look at the challenges affecting our world today, many come to mind - energy demand, food security and climate change, just to name a few.   Biotechnology provides tools to meet all of these challenges.  The sustainable farming practices afforded to today’s modern farmers allow us to produce more food, fuel and fiber on less land with less environmental impact.

New vaccines employing biotech innovations are changing the way we prevent illness.  Dr. Targan explains how biotech researchers are discovering new ways to prevent illnesses such as HPV, hepatitis-B, meningitis, and even the flu through new and improved research, manufacturing, and delivery mechanisms.

Download to listen or view the podcast.

We issued a late breaking call for sessions for the 2010 BIO International Convention today. Open for 4 Days  - Due Thursday, February 4th http://tinyurl.com/yej8j8c To respond to requests for recent and timely session topics, we are accepting six new late-breaking sessions for the 2010 BIO International Convention.

BIOtech Now’s Tracy Krughoff talks with Steve Perrin, Chief Executive Officer and Chief Scientific Officer of the ALS Therapy Development Institute, which is one of the advocacy organizations presenting at the upcoming BIO CEO & Investor Conference, being held Feb 8-9 in New York City.

Listen to the podcast:
http://www.bio.org/podcasts/pe

Patient advocacy groups have many different roles.  They are educators, they provide a support system for individuals and families of people living with illness, they lobby for increased research, and are increasingly providing funding to biotech companies to encourage further research and development of promising, and potentially life-saving therapies.  At the 2009 BIO International Convention, we met with patients  and patient advocates to learn more about how advocacy groups are working together with biotech researchers to promote innovative research and creation of therapies that may one d

Biotech Now’s Tracy Krughoff talks to Dr. Marc Hurlbert, who is Director of the Avon Foundation Breast Cancer Crusade.

Biosimilars, also known as follow-on biologics, may eventually expand access and provide patients a more affordable alternative to innovative, lifesaving medicines. However, there are a few important safeguards that must be put into place before these “similar but not the same” versions of biologics can be safely introduced to the public.  Join Dr.

Biofuels is big in Iowa. So big in fact, that according to domesticfuel.com

“Iowa State University will get $8 million of a $78 million U.S.

Last summer, BIO joined with former Vermont Governor Howard Dean to advocate for biosimilar legislation that protects patient safety and promotes necessary incentives for continued innovation of biologics.